Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: JAMA Ophthalmol. 2015 Dec;133(12):1459–1463. doi: 10.1001/jamaophthalmol.2015.3119

Figure 2. Iris and ciliary body toxicity.

Figure 2

Patient 3 with iris abnormality in the meridian of the intravitreous injection (A). Anterior segment OCT and UBM images demonstrate synechae, iris thinning and loss of iris crypts, and ciliary body atrophy (B and C). By comparison, the unaffected normal left iris is shown (D, E and F).